相关实验视频

Updated: Apr 11, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

实验和计算分析新发现的肌酸转运体SLC6A8A8中的病原性突变

Evandro Ferrada¹, Tabea Wiedmer¹, Wen-An Wang¹

¹CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Journal of molecular biology

|December 9, 2023

概括

这项研究调查了与肌酸缺乏综合征 (CDS) 相关的肌酸载体 (SLC6A8) 的遗传变异. 研究人员澄清了15种变异的致病性,发现了新的疾病机制和两种新突变.

科学领域:

生物化学生物化学
遗传学遗传学是一个
神经科学是一个神经科学.

背景情况:

肌酸对于肌肉和神经细胞中的能量至关重要.
肌酸载体 (SLC6A8) 的突变会导致肌酸缺乏综合征 (CDS),一种精神残疾形式.
80种SLC6A8突变与CDS有关,但许多变体的影响仍然未知.

研究的目的:

调查SLC6A8中30个误解变异的功能影响,包括15个未知意义的变异.
阐明这些变体的致病机制及其在CDS中的作用.
为了识别与CDS相关的新型SLC6A8变异.

主要方法:

在HEK293细胞中表达SLC6A8变异,以评估局部化和传输活动.
计算建模用于预测变异效应和稳定性变化.
载体构造和质谱学对载体构造的同质建模,以研究蛋白质相互作用.
蛋白质复合体的in silico分析,以了解变异对相互作用接口的影响.

主要成果:

15种未知意义的变异被明确,揭示了不同的致病机制.
在患有肌酸缺乏综合征的患者中发现了两种新的致病变体.
在 silico 模型显示了变异如何影响 SLC6A8 相互作用,并导致 ER 蛋白伴侣丰富.

结论:

这项研究澄清了众多SLC6A8变异的致病性,扩大了我们对CDS的理解.
不同的分子机制是SLC6A8相关疾病的基础.
鉴定新型变异有助于诊断和管理肌酸缺乏综合征.

关键词:

创造蛋白是一种创造性蛋白质.肌酸缺乏症综合征是什么意思肌酸运输体是什么? 肌酸运输体是什么?遗传变异是一种遗传变异.溶液载体是溶解物质的载体

更多相关视频

A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

Published on: April 30, 2018

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

相关概念视频

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...